Methylprednisolone Completed Phase 3 Trials for Recurrent Adult Acute Lymphoblastic Leukemia / Graft Versus Host Disease (GVHD) Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care3
clinicaltrials.gov IdentifierTitleDrugs
NCT00929695Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease
NCT00043147Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease